Wei‐Ru Lin
Impact in
- Endocrinology top 5%
- Infections and bacterial resistance
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 18
- Hepatitis B Virus Studies 3
-
- Tuberculosis Research and Epidemiology 7
- Co-authors
- Yen‐Hsu Chen (38 shared papers)Po‐Liang Lu (36 shared papers)Tun‐Chieh Chen (35 shared papers)Chun‐Yu Lin (34 shared papers)Chi‐Yu Chen (2 shared papers)Ko Chang (10 shared papers)Jih‐Jin Tsai (10 shared papers)Pei‐Ming Huang (5 shared papers)
- Journals
- Journal of Microbiology Immunology and Infection (9 papers)PLoS ONE (3 papers)BMC Infectious Diseases (3 papers)The American Journal of the Medical Sciences (3 papers)International Journal of Infectious Diseases (2 papers)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Wei‐Ru Lin
51 papers receiving 931 citations
Peers
Comparison fields: 5 of 112
- Endocrinology 138
- Molecular Medicine 121
- Infectious Diseases 269
- Parasitology 74
- Applied Microbiology and Biotechnology 19
Countries citing papers authored by Wei‐Ru Lin
This map shows the geographic impact of Wei‐Ru Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ru Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ru Lin more than expected).
Fields of papers citing papers by Wei‐Ru Lin
This network shows the impact of papers produced by Wei‐Ru Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ru Lin. The network helps show where Wei‐Ru Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Ru Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 124 | |
| 2 | 2010 | 75 | |
| 3 | 2012 | 51 | |
| 4 | 2010 | 44 | |
| 5 | 2014 | 42 | |
| 6 | 2008 | 41 | |
| 7 | 2010 | 37 | |
| 8 | 2013 | 34 | |
| 9 | 2017 | 30 | |
| 10 | 2009 | 26 | |
| 11 | 2012 | 26 | |
| 12 | 2011 | 23 | |
| 13 | Clinical features and prognostic factors of emphysematous urinary tract infection. | 2009 | 23 |
| 14 | 2010 | 23 | |
| 15 | 2006 | 21 | |
| 16 | Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates. | 2008 | 21 |
| 17 | 2012 | 20 | |
| 18 | 2014 | 20 | |
| 19 | 2007 | 20 | |
| 20 | 2013 | 18 |
About Wei‐Ru Lin
Wei‐Ru Lin is a scholar working on Epidemiology, Infectious Diseases, Surgery, Public Health, Environmental and Occupational Health and Endocrinology, having authored 54 papers that have together received 956 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (7 papers), Infectious Diseases and Tuberculosis (5 papers), Vector-borne infectious diseases (4 papers), Hepatitis C virus research (4 papers), Diagnosis and treatment of tuberculosis (4 papers), Streptococcal Infections and Treatments (3 papers), Hepatitis B Virus Studies (3 papers) and Antibiotic Resistance in Bacteria (3 papers). The work is most often cited by research in Endocrinology (138 citations), Molecular Medicine (121 citations), Infectious Diseases (269 citations), Parasitology (74 citations) and Applied Microbiology and Biotechnology (19 citations). Wei‐Ru Lin has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Yen‐Hsu Chen, Po‐Liang Lu, Tun‐Chieh Chen, Chun‐Yu Lin, Chi‐Yu Chen, Ko Chang, Jih‐Jin Tsai, Pei‐Ming Huang, Jong‐Rung Tsai and Tzu-Pin Wang. Their work appears in journals such as Journal of Microbiology Immunology and Infection, PLoS ONE, BMC Infectious Diseases, The American Journal of the Medical Sciences and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.